Novo Nordisk A/S (NVO)
Novo Nordisk A/S Statistics
Share Statistics
Novo Nordisk A/S has 4.48B shares outstanding. The number of shares has increased by 1.31% in one year.
| Shares Outstanding | 4.48B |
| Shares Change (YoY) | 1.31% |
| Shares Change (QoQ) | 2.94% |
| Owned by Institutions (%) | 7.58% |
| Shares Floating | 4.48B |
| Failed to Deliver (FTD) Shares | 6 |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 8.27M, so 0.2% of the outstanding shares have been sold short.
| Short Interest | 8.27M |
| Short % of Shares Out | 0.2% |
| Short % of Float | 0.2% |
| Short Ratio (days to cover) | 0.85 |
Valuation Ratios
The PE ratio is 27.53 and the forward PE ratio is 3.06. Novo Nordisk A/S's PEG ratio is 0.19.
| PE Ratio | 27.53 |
| Forward PE | 3.06 |
| PS Ratio | 9.57 |
| Forward PS | 0.6 |
| PB Ratio | 19.38 |
| P/FCF Ratio | 39.91 |
| PEG Ratio | 0.19 |
Enterprise Valuation
Novo Nordisk A/S has an Enterprise Value (EV) of 3,143.9B.
| EV / Earnings | 31.13 |
| EV / Sales | 10.83 |
| EV / EBITDA | 22.89 |
| EV / EBIT | 24.5 |
| EV / FCF | 45.13 |
Financial Position
The company has a current ratio of 0.74, with a Debt / Equity ratio of 0.72.
| Current Ratio | 0.74 |
| Quick Ratio | 0.55 |
| Debt / Equity | 0.72 |
| Total Debt / Capitalization | 41.74 |
| Cash Flow / Debt | 1.18 |
| Interest Coverage | 78.26 |
Financial Efficiency
Return on equity (ROE) is 0.7% and return on capital (ROIC) is 41.38%.
| Return on Equity (ROE) | 0.7% |
| Return on Assets (ROA) | 0.22% |
| Return on Capital (ROIC) | 41.38% |
| Revenue Per Employee | $3,805,968.39 |
| Profits Per Employee | $1,323,530.18 |
| Employee Count | 76,302 |
| Asset Turnover | 0.62 |
| Inventory Turnover | 1.09 |
Taxes
| Income Tax | 26.2B |
| Effective Tax Rate | 0.21 |
Stock Price Statistics
The stock price has increased by -45.38% in the last 52 weeks. The beta is 0.17, so Novo Nordisk A/S's price volatility has been higher than the market average.
| Beta | 0.17 |
| 52-Week Price Change | -45.38% |
| 50-Day Moving Average | 82.71 |
| 200-Day Moving Average | 111.35 |
| Relative Strength Index (RSI) | 29.92 |
| Average Volume (20 Days) | 8.4M |
Income Statement
In the last 12 months, Novo Nordisk A/S had revenue of 290.4B and earned 100.99B in profits. Earnings per share was 22.68.
| Revenue | 290.4B |
| Gross Profit | 245.88B |
| Operating Income | 128.34B |
| Net Income | 100.99B |
| EBITDA | 137.38B |
| EBIT | 128.34B |
| Earnings Per Share (EPS) | 22.68 |
Balance Sheet
The company has 15.65B in cash and 102.79B in debt, giving a net cash position of -87.13B.
| Cash & Cash Equivalents | 15.65B |
| Total Debt | 102.79B |
| Net Cash | -87.13B |
| Retained Earnings | 144.45B |
| Total Assets | 465.8B |
| Working Capital | -56.63B |
Cash Flow
In the last 12 months, operating cash flow was 120.97B and capital expenditures -51.31B, giving a free cash flow of 69.66B.
| Operating Cash Flow | 120.97B |
| Capital Expenditures | -51.31B |
| Free Cash Flow | 69.66B |
| FCF Per Share | 15.64 |
Margins
Gross margin is 84.67%, with operating and profit margins of 44.19% and 34.78%.
| Gross Margin | 84.67% |
| Operating Margin | 44.19% |
| Pretax Margin | 43.8% |
| Profit Margin | 34.78% |
| EBITDA Margin | 47.31% |
| EBIT Margin | 44.19% |
| FCF Margin | 23.99% |
Dividends & Yields
NVO pays an annual dividend of $1.3, which amounts to a dividend yield of 1.81%.
| Dividend Per Share | $1.30 |
| Dividend Yield | 1.81% |
| Dividend Growth (YoY) | -15.32% |
| Payout Ratio | 39.52% |
| Earnings Yield | 32.34% |
| FCF Yield | 22.2% |
Analyst Forecast
The average price target for NVO is $160, which is 128.1% higher than the current price. The consensus rating is "Buy".
| Price Target | $160 |
| Price Target Difference | 128.1% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
Stock Splits
The last stock split was on Sep 20, 2023. It was a forward split with a ratio of 2:1.
| Last Split Date | Sep 20, 2023 |
| Split Type | forward |
| Split Ratio | 2:1 |
Scores
| Altman Z-Score | 2.44 |
| Piotroski F-Score | 5 |